African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5182

Full Length Research Paper

Extended-spectrum β-lactamase production and antimicrobial resistance in Klebsiella pneumoniae and Escherichia coli among inpatients and outpatients of Jimma University Specialized Hospital, South-West, Ethiopia

Shewki Moga Siraj*
  • Shewki Moga Siraj*
  • Ethiopian Public Health Institute (EPHI), National Tuberculosis Reference Laboratory, Addis Ababa, Ethiopia
  • Google Scholar
Solomon Ali
  • Solomon Ali
  • Department of Medical Laboratory Science and Pathology, Jimma University, Ethiopia
  • Google Scholar
Beyene Wondafrash
  • Beyene Wondafrash
  • Post Graduate Study Coordinator, Jimma University, Ethiopia
  • Google Scholar


  •  Received: 30 May 2014
  •  Accepted: 06 October 2014
  •  Published: 22 October 2014

References

Al-Jasser AM (2006). Extended-Spectrum Beta-Lactamases (ESBLs). A Global Problem. Kuwait Med J. 38(3): 171-185.

 

Al-Zarouni M, Senok A, Rashid F, Al-Jesmi SM, Panigrahi D (2008). Prevalence and antimicrobial susceptibility pattern of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the United Arab Emirates. Med. Princ. Pract.17: 32-36.
Crossref

 
 

Bisson G, Fishman NO, Edelstein PH, Lautenbach E (2002). Extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence. Infect. Control Hosp. Epidemiol. 23:254-260.
Crossref

 
 

Clinical and Laboratory Standard Institute WP (CLSI) (2005). Clinical and Laboratory Standard Methods. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. M100-S115.

 
 

Galas M, Decousser JW, Breton N, Godard T, Allouch PY, Pina P, Collège de Bactériologie Virologie Hygiène (ColBVH) Study Group (2008). Nationwide Study of the Prevalence, Characteristics, and Molecular Epidemiology of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France. Antimicrob. Agents Chemother. 52(2): 786–789.
Crossref

 
 

Giamarellou H (2005). Multidrug resistance in Gram-negative bacteria that produce extended-spectrum β-lactamases (ESBLs). Clin. Microbiol. Infect. 11(Suppl. 4): 1–16.
Crossref

 
 

Hawser SP, Bouchillon SK, Lascols C, Hackel M, Hoban DJ, Badal RE, Cantón R (2011). Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum b-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008–2009). Clin. Microbiol. Infect. 18(3):253-9.
Crossref

 
 

Holbrook KA, Lowy FD (1998). β-Lactam Antibiotics. Cancer Invest. 16: 405-412.
Crossref

 
 

Jacoby GA, Sutton L (1991). Properties of plasmids responsible for production of extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 35: 164-169.
Crossref

 
 

Jarlier V, Nicolas MH, Fournier G, Philippon A (1988). Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactama gents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10: 867-878.
Crossref

 
 

Kader AA, Kumar A, Kamath KA (2007). Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect. Control Hosp. Epidemiol. 28: 1114-1116.
Crossref

 
 

Kang CI, Kim SH, Bang JW, Kim HB, Kim NJ, Kim EC et al. (2006). Community-Acquired versus Nosocomial Klebsiella pneumoniae Bacteremia: Clinical Features, Treatment Outcomes, and Clinical Implication of Antimicrobial Resistance. J. Korean Med. Sci. 21: 816-822.
Crossref

 
 

Kariuki S, Revathi G, Corkill J, Kiiru J, Mwituria J, Mirza N, Hart CA (2007). Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams. J. Infect. Dev. Ctries. 1(3): 257-262.
Pubmed

 
 

Kim MH, Lee HJ, Park KS, Suh JT (2010). Molecular Characteristics of Extended Spectrum β-Lactamases in Escherichia coli and Klebsiella pneumoniae and the Prevalence of qnr in Extended Spectrum β-Lactamase Isolates in a Tertiary Care Hospital in Korea. Yonsei Med. J. 51(5): 768-774.
Crossref

 
 

Koneman EW, Allen SD, Janda WM, Win WC (2006). The Enterobacteriaceae. In: Color Atlas and Text Book of Diagnostic Microbiology. 6th ed. 211-302.

 
 

Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO (2001). Extended-spectrum b-lactamase–producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin. Infect. Dis. 32: 1162–1171.
Crossref

 
 

Levy SSS, Mello MJG., Gusmao-filho FAR, Correia JB (2010). Colonisation by extended-spectrum b-lactamase-producing Klebsiella spp. in a paediatric intensive care unit. J. Hosp. Infect. 76: 66-69.
Crossref

 
 

Livermore DM (1995). β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8: 557–584.
Pubmed

 
 

Livermore DM (1998). β-lactamase-mediated resistance and oppor-tunities for its control. J. Antimicrob. Chemother. 41(Suppl): 25–41.
Crossref

 
 

Moyo SJ, Aboud S, Kasubi M, Lyamuya EF, Maselle SY (2010). Antimicrobial resistance among producers and non-producers of extended spectrum beta lactamases in urinary isolates at a tertiary Hospital in Tanzania. BMC Res. Notes 3:348.
Crossref

 
 

Mshana SE, Kamugisha E, Mirambo M, Chakraborty T, Lyamuya EF (2009). Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania. BMC Res. Notes 2:49.
Crossref

 
 

Niki M, Hirai I, Yoshinaga A, Ulzii-Orshikh L, Nakata A, Yamamoto A, Yamamoto M, Yamamoto Y (2011). Extended-spectrum b-lactamase-producing Escherichia coli strains in the feces of carriers contribute substantially to urinary tract infections in these patients. Infection 39(5):467-471.
Crossref

 
 

Pitout JDD, Laupland KB (2008). Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public health concern. Lancet Infect. Dis. 8:159-166.
Crossref

 
 

Pitout JDD, Nordmann P, Laupland KB, Poirel L (2005). Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56: 52–59.
Crossref

 
 

Rossolini GM, Mantengoli E (2008). Antimicrobial resistance in Europe and its potential impact on empirical therapy. Clin. Microbiol. Infect. 14 (Suppl. 6): 2–8.
Crossref

 
 

Shah AA, Hasan F, Ahmed S, Hameed A (2003). Prevalence of extended-spectrum beta-lactamases in nosocomial and outpatients (ambulatory). Pak. J. Med. Sci. 19: 187-191.

 
 

Shah AA, Hasan F, Ahmed S, Hameed A (2004). Extended-Spectrum β-Lactamases (ESBLs): Characterization, Epidemiology and Detection. Crit. Rev. Microb. 30(1): 25–32.
Crossref

 
 

Turner PJ (2005). Extended-Spectrum β-Lactamases. Clin. Infect. Dis. 41: S273-S275.
Crossref

 
 

Zaki MS (2007). Extended Spectrum β-Lactamases among Gram-negative bacteria from an Egyptian pediatric hospital: a two-year experience. J. Infect. Dev. Ctries. 1(3): 269-274.